prodent laboratories limited
prodent laboratories limited Company Information
Company Number
02573112
Next Accounts
Sep 2025
Shareholders
aesthetic world holdings ltd
Group Structure
View All
Industry
Manufacture of medical and dental instruments and supplies
Registered Address
85 great portland street, london, W1W 7LT
Website
www.prodent-lab.co.ukprodent laboratories limited Estimated Valuation
Pomanda estimates the enterprise value of PRODENT LABORATORIES LIMITED at £301.7k based on a Turnover of £384.8k and 0.78x industry multiple (adjusted for size and gross margin).
prodent laboratories limited Estimated Valuation
Pomanda estimates the enterprise value of PRODENT LABORATORIES LIMITED at £4.3m based on an EBITDA of £948.8k and a 4.48x industry multiple (adjusted for size and gross margin).
prodent laboratories limited Estimated Valuation
Pomanda estimates the enterprise value of PRODENT LABORATORIES LIMITED at £3.4m based on Net Assets of £1.5m and 2.23x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Prodent Laboratories Limited Overview
Prodent Laboratories Limited is a live company located in london, W1W 7LT with a Companies House number of 02573112. It operates in the manufacture of medical and dental instruments and supplies sector, SIC Code 32500. Founded in January 1991, it's largest shareholder is aesthetic world holdings ltd with a 100% stake. Prodent Laboratories Limited is a mature, micro sized company, Pomanda has estimated its turnover at £384.8k with rapid growth in recent years.
Upgrade for unlimited company reports & a free credit check
Prodent Laboratories Limited Health Check
Pomanda's financial health check has awarded Prodent Laboratories Limited a 4.5 rating. We use a traffic light system to show it exceeds the industry average on 4 measures and has 4 areas for improvement. Company Health Check FAQs
4 Strong
2 Regular
4 Weak
Size
annual sales of £384.8k, make it smaller than the average company (£17.8m)
- Prodent Laboratories Limited
£17.8m - Industry AVG
Growth
3 year (CAGR) sales growth of 36%, show it is growing at a faster rate (6.2%)
- Prodent Laboratories Limited
6.2% - Industry AVG
Production
with a gross margin of 24.5%, this company has a higher cost of product (37.4%)
- Prodent Laboratories Limited
37.4% - Industry AVG
Profitability
an operating margin of 246.6% make it more profitable than the average company (6%)
- Prodent Laboratories Limited
6% - Industry AVG
Employees
with 2 employees, this is below the industry average (90)
- Prodent Laboratories Limited
90 - Industry AVG
Pay Structure
on an average salary of £49.5k, the company has an equivalent pay structure (£49.5k)
- Prodent Laboratories Limited
£49.5k - Industry AVG
Efficiency
resulting in sales per employee of £192.4k, this is equally as efficient (£179.4k)
- Prodent Laboratories Limited
£179.4k - Industry AVG
Debtor Days
it gets paid by customers after 69 days, this is later than average (50 days)
- Prodent Laboratories Limited
50 days - Industry AVG
Creditor Days
There is insufficient data available for this Key Performance Indicator!
- Prodent Laboratories Limited
- - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- Prodent Laboratories Limited
- - Industry AVG
Cash Balance
has cash to cover current liabilities for 45 weeks, this is more cash available to meet short term requirements (11 weeks)
45 weeks - Prodent Laboratories Limited
11 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 6.9%, this is a lower level of debt than the average (41.9%)
6.9% - Prodent Laboratories Limited
41.9% - Industry AVG
PRODENT LABORATORIES LIMITED financials
Prodent Laboratories Limited's latest turnover from December 2023 is estimated at £384.8 thousand and the company has net assets of £1.5 million. According to their latest financial statements, we estimate that Prodent Laboratories Limited has 2 employees and maintains cash reserves of £98.8 thousand as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Dec 2023 | Aug 2022 | Aug 2021 | Aug 2020 | Aug 2019 | Aug 2018 | Aug 2017 | Aug 2016 | Aug 2015 | Aug 2014 | Aug 2013 | Aug 2012 | Aug 2011 | Aug 2010 | Aug 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | |||||||||||||||
| Other Income Or Grants | |||||||||||||||
| Cost Of Sales | |||||||||||||||
| Gross Profit | |||||||||||||||
| Admin Expenses | |||||||||||||||
| Operating Profit | |||||||||||||||
| Interest Payable | |||||||||||||||
| Interest Receivable | |||||||||||||||
| Pre-Tax Profit | |||||||||||||||
| Tax | |||||||||||||||
| Profit After Tax | |||||||||||||||
| Dividends Paid | |||||||||||||||
| Retained Profit | |||||||||||||||
| Employee Costs | |||||||||||||||
| Number Of Employees | 2 | 2 | 2 | 2 | |||||||||||
| EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Dec 2023 | Aug 2022 | Aug 2021 | Aug 2020 | Aug 2019 | Aug 2018 | Aug 2017 | Aug 2016 | Aug 2015 | Aug 2014 | Aug 2013 | Aug 2012 | Aug 2011 | Aug 2010 | Aug 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Tangible Assets | |||||||||||||||
| Intangible Assets | 1,353 | 2,705 | 4,058 | ||||||||||||
| Investments & Other | |||||||||||||||
| Debtors (Due After 1 year) | |||||||||||||||
| Total Fixed Assets | 1,353 | 2,705 | 4,058 | ||||||||||||
| Stock & work in progress | |||||||||||||||
| Trade Debtors | 73,677 | 63,586 | 48,681 | 24,305 | 589,332 | 509,408 | 50,142 | 51,253 | 501,801 | 392,051 | 319,708 | 214,283 | 177,798 | 238,862 | 233,292 |
| Group Debtors | 1,469,354 | 639,354 | 606,503 | 583,462 | |||||||||||
| Misc Debtors | 371,262 | 268,228 | |||||||||||||
| Cash | 98,832 | 152,648 | 8,155 | 51,330 | 12,220 | 16,587 | 30,321 | 44,966 | 8,404 | 11,959 | 11,606 | 5,434 | 20,677 | 7,117 | 431 |
| misc current assets | |||||||||||||||
| total current assets | 1,641,863 | 855,588 | 663,339 | 659,097 | 601,552 | 525,995 | 451,725 | 364,447 | 510,205 | 404,010 | 331,314 | 219,717 | 198,475 | 245,979 | 233,723 |
| total assets | 1,641,863 | 855,588 | 663,339 | 659,097 | 601,552 | 525,995 | 451,725 | 364,447 | 510,205 | 404,010 | 331,314 | 221,070 | 201,180 | 250,037 | 233,723 |
| Bank overdraft | |||||||||||||||
| Bank loan | |||||||||||||||
| Trade Creditors | 54,760 | 50,448 | 59,407 | 59,048 | 54,696 | 48,074 | 58,276 | ||||||||
| Group/Directors Accounts | 36,000 | ||||||||||||||
| other short term finances | |||||||||||||||
| hp & lease commitments | |||||||||||||||
| other current liabilities | 77,272 | 43,563 | 24,714 | 16,842 | 20,317 | 20,593 | 23,333 | 21,499 | |||||||
| total current liabilities | 113,272 | 43,563 | 24,714 | 16,842 | 20,317 | 20,593 | 23,333 | 21,499 | 54,760 | 50,448 | 59,407 | 59,048 | 54,696 | 48,074 | 58,276 |
| loans | |||||||||||||||
| hp & lease commitments | |||||||||||||||
| Accruals and Deferred Income | |||||||||||||||
| other liabilities | |||||||||||||||
| provisions | |||||||||||||||
| total long term liabilities | |||||||||||||||
| total liabilities | 113,272 | 43,563 | 24,714 | 16,842 | 20,317 | 20,593 | 23,333 | 21,499 | 54,760 | 50,448 | 59,407 | 59,048 | 54,696 | 48,074 | 58,276 |
| net assets | 1,528,591 | 812,025 | 638,625 | 642,255 | 581,235 | 505,402 | 428,392 | 342,948 | 455,445 | 353,562 | 271,907 | 162,022 | 146,484 | 201,963 | 175,447 |
| total shareholders funds | 1,528,591 | 812,025 | 638,625 | 642,255 | 581,235 | 505,402 | 428,392 | 342,948 | 455,445 | 353,562 | 271,907 | 162,022 | 146,484 | 201,963 | 175,447 |
| Dec 2023 | Aug 2022 | Aug 2021 | Aug 2020 | Aug 2019 | Aug 2018 | Aug 2017 | Aug 2016 | Aug 2015 | Aug 2014 | Aug 2013 | Aug 2012 | Aug 2011 | Aug 2010 | Aug 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||||||||||
| Operating Profit | |||||||||||||||
| Depreciation | |||||||||||||||
| Amortisation | 1,353 | 1,352 | 1,353 | 1,353 | |||||||||||
| Tax | |||||||||||||||
| Stock | |||||||||||||||
| Debtors | 840,091 | 47,756 | 47,417 | 18,435 | 79,924 | 88,004 | 101,923 | -182,320 | 109,750 | 72,343 | 105,425 | 36,485 | -61,064 | 5,570 | 233,292 |
| Creditors | -54,760 | 4,312 | -8,959 | 359 | 4,352 | 6,622 | -10,202 | 58,276 | |||||||
| Accruals and Deferred Income | 33,709 | 18,849 | 7,872 | -3,475 | -276 | -2,740 | 1,834 | 21,499 | |||||||
| Deferred Taxes & Provisions | |||||||||||||||
| Cash flow from operations | |||||||||||||||
| Investing Activities | |||||||||||||||
| capital expenditure | |||||||||||||||
| Change in Investments | |||||||||||||||
| cash flow from investments | |||||||||||||||
| Financing Activities | |||||||||||||||
| Bank loans | |||||||||||||||
| Group/Directors Accounts | 36,000 | ||||||||||||||
| Other Short Term Loans | |||||||||||||||
| Long term loans | |||||||||||||||
| Hire Purchase and Lease Commitments | |||||||||||||||
| other long term liabilities | |||||||||||||||
| share issue | |||||||||||||||
| interest | |||||||||||||||
| cash flow from financing | |||||||||||||||
| cash and cash equivalents | |||||||||||||||
| cash | -53,816 | 144,493 | -43,175 | 39,110 | -4,367 | -13,734 | -14,645 | 36,562 | -3,555 | 353 | 6,172 | -15,243 | 13,560 | 6,686 | 431 |
| overdraft | |||||||||||||||
| change in cash | -53,816 | 144,493 | -43,175 | 39,110 | -4,367 | -13,734 | -14,645 | 36,562 | -3,555 | 353 | 6,172 | -15,243 | 13,560 | 6,686 | 431 |
prodent laboratories limited Credit Report and Business Information
Prodent Laboratories Limited Competitor Analysis
Perform a competitor analysis for prodent laboratories limited by selecting its closest rivals, whether from the MANUFACTURING sector, other micro companies, companies in W1W area or any other competitors across 12 key performance metrics.
prodent laboratories limited Ownership
PRODENT LABORATORIES LIMITED group structure
Prodent Laboratories Limited has no subsidiary companies.
Ultimate parent company
GENERAL PARTNER OF ANSOR FUND I LP
#0162806
2 parents
PRODENT LABORATORIES LIMITED
02573112
prodent laboratories limited directors
Prodent Laboratories Limited currently has 2 directors. The longest serving directors include Mr Thomas Lavery (Aug 2023) and Mr Kenneth Burns (Aug 2023).
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Mr Thomas Lavery | England | 56 years | Aug 2023 | - | Director |
| Mr Kenneth Burns | England | 44 years | Aug 2023 | - | Director |
P&L
December 2023turnover
384.8k
+33%
operating profit
948.8k
0%
gross margin
24.6%
-5.04%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
December 2023net assets
1.5m
+0.88%
total assets
1.6m
+0.92%
cash
98.8k
-0.35%
net assets
Total assets minus all liabilities
prodent laboratories limited company details
company number
02573112
Type
Private limited with Share Capital
industry
32500 - Manufacture of medical and dental instruments and supplies
incorporation date
January 1991
age
34
incorporated
UK
ultimate parent company
accounts
Audit Exemption Subsidiary
last accounts submitted
December 2023
previous names
carryload limited (February 1991)
accountant
-
auditor
-
address
85 great portland street, london, W1W 7LT
Bank
HSBC BANK PLC
Legal Advisor
-
prodent laboratories limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We found 4 charges/mortgages relating to prodent laboratories limited. Currently there are 2 open charges and 2 have been satisfied in the past.
prodent laboratories limited Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for PRODENT LABORATORIES LIMITED. This can take several minutes, an email will notify you when this has completed.
prodent laboratories limited Companies House Filings - See Documents
| date | description | view/download |
|---|
